Extended outcomes of intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastases

被引:1
|
作者
Chan, Dexter Yak Seng
Syn, Nicholas
Neogh, Cui Ting
Phua, Niam Sin
Elva
Ho, Jinghsan
Sundar, Raghav
Tan, Chee Seng
Ngoi, Natalie
Chee, Cheng Ean
Shabbir, Asim
So, Jimmy
Yong, Wei-Peng
机构
[1] Natl Univ Hlth Syst, Singapore, Singapore
[2] Natl Univ Canc Inst, Singapore, Singapore
[3] Natl Univ Canc Inst Singapore, Singapore, Singapore
[4] Natl Univ Singapore Hosp, Singapore, Singapore
关键词
D O I
10.1200/JCO.2018.36.4_suppl.125
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
125
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Hyperthermic intraperitoneal chemotherapy in prevention of gastric cancer metachronous peritoneal metastases: a systematic review
    Reutovich, Mikhail Yu
    Krasko, Olga, V
    Sukonko, Oleg G.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 : S5 - S17
  • [22] Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
    Mariani, Antoine
    Zaanan, Aziz
    Glehen, Olivier
    Karoui, Mehdi
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (02) : 816 - 817
  • [23] Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
    Chia, Daryl K. A.
    Sundar, Raghav
    Kim, Guowei
    Ang, Jia Jun
    Shabbir, Asim
    So, Jimmy B. Y.
    Yong, Wei Peng
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (03) : 1889 - 1890
  • [24] Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
    Daryl K. A. Chia
    Raghav Sundar
    Guowei Kim
    Jia Jun Ang
    Asim Shabbir
    Jimmy B. Y. So
    Wei Peng Yong
    [J]. Annals of Surgical Oncology, 2023, 30 (3) : 1889 - 1890
  • [25] Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
    Daryl K. A. Chia
    Raghav Sundar
    Guowei Kim
    Jia Jun Ang
    Jeffrey H. Y. Lum
    Min En Nga
    Giap Hean Goh
    Ju Ee Seet
    Cheng Ean Chee
    Hon Lyn Tan
    Jingshan Ho
    Natalie Y. L. Ngoi
    Matilda X. W. Lee
    Vaishnavi Muthu
    Gloria H. J. Chan
    Angela S. L. Pang
    Yvonne L. E. Ang
    Joan R. E. Choo
    Joline S. J. Lim
    Jun Liang Teh
    Aung Lwin
    Yuen Soon
    Asim Shabbir
    Jimmy B. Y. So
    Wei Peng Yong
    [J]. Annals of Surgical Oncology, 2022, 29 : 8597 - 8605
  • [26] Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases
    Antoine Mariani
    Aziz Zaanan
    Olivier Glehen
    Mehdi Karoui
    [J]. Annals of Surgical Oncology, 2023, 30 : 816 - 817
  • [27] Gastrectomy after response to intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology
    Ishigami, H.
    Yamaguchi, H.
    Yamashita, H.
    Asakage, M.
    Kitayama, J.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [28] Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings
    Ishigami, Hironori
    Yamaguchi, Hironori
    Yamashita, Hiroharu
    Asakage, Masahiro
    Kitayama, Joji
    [J]. GASTRIC CANCER, 2017, 20 : S128 - S134
  • [29] Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings
    Hironori Ishigami
    Hironori Yamaguchi
    Hiroharu Yamashita
    Masahiro Asakage
    Joji Kitayama
    [J]. Gastric Cancer, 2017, 20 : 128 - 134
  • [30] Intraperitoneal free cancer cells in gastric cancer: pathology of peritoneal carcinomatosis and rationale for intraperitoneal chemotherapy/hyperthermic intraperitoneal chemotherapy in gastric cancer
    Ji, Zhong-He
    Peng, Kai-Wen
    Li, Yan
    [J]. TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 1